Ulrich Neumann, MBA MSc MA BSc BA currently serves as Director for Market Access Scientific and External Strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson. At Janssen, he is part of a senior team developing models and evidence generation for health economic policy evaluations, focusing on domains such as value assessment methodologies, healthcare financing and value-based insurance design. Ulrich previously worked at the drug development platform Certara and the population health intelligence consultancy Analytica Laser.  He holds an MBA from Imperial College London, an MSc from the London School of Economics and an MA from the University of Southern California, Annenberg School and Marshall School of Business. His undergraduate degrees are in Public Administration (BSc) and Multi-level Governance (BA). The author of two books, he has published various articles, whitepapers, reports, and posters on critical pharmaceutical policy and managed care topics.